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Pathological polymorphism of clotting factor V, com-
prising Arg506Gln substitution in the factor V molecule, 
is commonly referred to as Factor V Leiden (FV Leiden). 
This substitution of a single amino acid results in reduced 
response to the activated protein C because Arg506 is the 
cleavage site for activated protein C on the activated fac-
tor V molecule. Factor V Leiden mutation is associated 
with an increased risk of venous thrombosis, seven-fold 
higher in heterozygous individuals and 80-fold higher 
in homozygous ones. Interestingly, this increased risk 
applies only to venous thromboembolism and does not 
concern arterial thrombosis [1]. Factor V Leiden is not 
the only known pathological polymorphism of clotting 
factor V. For example, a rare polymorphism, FV Cam-
bridge, comprises Arg306Thr substitution, and FV Hong 
Kong, which is found primarily in southeastern Asians – 
an Arg306Gly substitution [2]. There are also other, less 
known polymorphisms of this clotting factor [3-5]. 
Factor V Leiden, although associated with throm-
botic burden, is very common in Europe, the Near and 
Middle East, and also in countries that were colonised by 
Europeans, especially those of Germanic origin (such as: 
North America and Australia). Therefore, some research-
ers speculated that this polymorphism presents with 
an unknown survival advantage that has facilitated the 
spread of this mutation in the human population. In this 
review we will argue against such a simple Darwinian 
evolutionary mechanism responsible for high prevalence 
of FV Leiden in some countries. Also, we will point out 
cultural, climatic, and geographic factors, which could 
possibly play a role. Finally, we will present some – of as 
yet unsolved – problems associated with the pre-history 
of Europe and the Near East, which potentially could be 
elucidated by studying current distribution of FV Leiden. 
Current distribution of FV Leiden 
polymorphism
Prevalence of FV Leiden in general populations dif-
fers widely between countries. It represents the most 
common heritable risk factor for thrombotic events in 
Indo-Europeans and some Semitic nations (Arabs and 
Jews). Prevalence of FV Leiden in the general population 
is the highest in the Near East, and in some countries of 
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abstraCt
Polymorphism of clotting factor V, comprising Arg506Gln substitution in the factor 
V molecule, commonly known as Factor V Leiden, represents the most common her-
itable risk factor for thrombotic events in Indo-Europeans and some Semitic nations. 
Although it is suggested that this mutation is associated with a survival advantage 
that has facilitated the spread of this polymorphism in the human population, in this 
paper we argue against such a Darwinian evolutionary mechanism responsible for the 
high prevalence of FV Leiden in some countries. Instead, we propose that cultural, cli-
matic, and geographic factors played a role. Taking into account the current distribu-
tion of FV Leiden polymorphism and the results of recent assessments of pre-historic 
human DNA, we suggest that actually the origin of FV Leiden mutation did not occur 
in the Near East, as is widely believed, but rather in a small isolated population of 
so-called Basal Eurasians, probably in northern Africa. This founder group probably 
migrated to the Near East during the Younger Dryas, a geological period associated 
with climate cooling. Here, they mixed with local people; still Factor V Leiden muta-
tion remained very prevalent in this population. The invention of agriculture, which 
took place approximately 2,000 years later, gave the descendants of Basal Eurasians an 
enormous advantage over hunter-gatherers, and probably enabled a successful spread 
of FV Leiden polymorphism to Europe, Central Asia, and towards the Indian sub-
continent.
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this region (Lebanon, Palestine, and Syria) it is as high as 
12-27% [6, 7]. In Europe the average prevalence of FV 
Leiden in general population is at the level of 3.5%, but 
it is also unevenly distributed, with a higher frequency in 
northern and southeastern Europe, and lower in western 
and eastern Europe (Fig. 1) [8]. Interestingly, FV Leiden 
mutation is almost completely absent in the Basques, 
an indigenous ethnic group inhabiting the region locat-
ed around the western end of the Pyrenees (north Spain 
and south-western France) [9, 10]. Similarly, this poly-
morphism is not found in East Asia, sub-Saharan Africa, 
among Greenland Eskimos and indigenous populations 
of the Americas, Australia, and Polynesia [6, 11, 12].  
origins of FV Leiden mutation
Zivelin et al. studied 117 Caucasians who were 
homozygous for FV Leiden mutation and concluded that 
this polymorphism most likely (p < 10–6) arose as a sin-
gle event. An estimation of probable time for the origin 
of FV Leiden mutation, based on analysis of two exons 
of this gene, revealed that it occurred either 21,000 or 
34,000 years ago, with the former time being more likely 
[13]. Many scientists suggested that a relative hyperco-
agulability in FV individuals might be advantageous in 
a case of severe bleeding related to trauma or delivery. 
Other potential evolutionary advantages associated with 
FV Leiden mutation, which were summarised by van 
Mens et al., include: less menstrual blood loss, decreased 
risk of intracranial bleeding, a milder clinical course of 
haemophilia, lower mortality in the case of sepsis, higher 
survival in acute respiratory distress syndrome, decreased 
risk of diabetic nephropathy, improved embryo implanta-
tion, higher sperm count, and higher fecundity in females 
[14-16].
Although theoretically plausible, in our opinion most 
of these mechanisms are not likely to have any evolution-
ary effect in pre-historic (i.e. before a writing system was 
invented) humans. For example, less menstrual blood loss 
was unlikely to play relevant role in pre-historic humans, 
since those females, similarly to present day women 
belonging to uneducated tribes in Africa, were likely to 
Fig. 1. Current distribution of Factor V Leiden polymorphism 
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menstruate rather infrequently, due to numerous preg-
nancies followed by several years of lactation. Non-trau-
matic fatal intracranial bleeding, such as the rupture 
of cerebral aneurysm, nowadays represents a very rare 
cause of death, and also in the past it was probably a spo-
radic event. Haemophilic individuals were very unlikely 
to survive to adult age in pre-historic times. Acute respi-
ratory distress syndrome and diabetic nephropathy repre-
sent clinical challenges of our era but not of pre-history. 
Also, a higher sperm count can be advantageous in some 
animals, but not in humans (perhaps with the exception 
of a theoretical strictly mono- or polygamic society, 
which is not the case here). We believe that only two of 
these mechanisms could possibly play a role: reduced 
bleeding in case of trauma and decreased sepsis-associat-
ed mortality. Regarding the first potential advantage, one 
can imagine that an individual with less severe bleeding 
could more easily survive an accident. Still, in pre-histor-
ic times probably most life-threatening traumas resulted 
from fighting with other humans (although there are no 
written records coming from that time, it is likely that 
behaviour of our pre-historic ancestors was similar to 
currently described customs of hunter-gatherer tribes 
of Papua, the Kalahari Desert, and the Amazon Jungle 
[17]). And while even 10-20% of mortalities in human 
pre-history, and also in these uncivilised tribes, resulted 
from homicide, a brutish way of killing probably gave 
no survival advantage for FV Leiden carriers. It should 
also be assumed that any potential survival benefit asso-
ciated with relative hypercoagulability would be reduced 
by an increased mortality due to venous thromboembo-
lism, which is often associated with non-fatal trauma. 
Regarding the second potential benefit associated with 
FV Leiden mutation – a relative resistance to sepsis – it 
should be remembered that infectious diseases became 
a real problem for humans only after domestication of 
animals and introduction of agriculture, when people 
started to live in groups large enough to enable an infec-
tious disease to stay active in the population (it is not pos-
sible in a small group of hunter-gatherers, where disease 
either kills all members of such a group, or all survivors 
become resistant; in both cases the disease can no longer 
attack humans, given that there is no animal reservoir of 
the microorganisms). Thus, during at least half of the his-
tory of FV Leiden: between 21,000 years ago (origin of 
this polymorphism) and 9,500 years ago (when agricul-
ture and pastoralism were invented) this potential mech-
anism could not be effective. Other non-infectious cases 
of sepsis, which represent an important source of mortal-
ity for present day humans (primarily elderly ones) are 
of unclear importance for pre-historic hunter-gatherers. 
Also, even if some researchers found an advantage asso-
ciated with FV Leiden mutation in sepsis patients [2], 
others were unable to demonstrate such an effect [18]. 
Importantly, population studies did not reveal a surviv-
al advantage in FV Leiden mutation carriers with sepsis 
[19, 20]. Thus, in our opinion FV Leiden represents rather 
neutral mutation in terms of evolutionary advantage. But 
if FV Leiden were indeed such a neutral polymorphism, 
there should have been other mechanisms responsible for 
the very high prevalence of this mutation in some pop-
ulations and low in the others. Still, we should look for 
these mechanisms outside of biology, focusing instead on 
history and geography.  
the basques
As has been already mentioned, FV Leiden poly-
morphism is not found among the Basques [9, 10]. The 
Basques represent a unique ethnic group, speaking a non- 
Indo-European language. Basque language (Euskara) 
is not linked to any contemporary existing tongue and 
is believed to be the only remnant of languages spoken 
in Europe before Neolithic migration of farmers, who 
introduced to Europe not only domestic animals and 
crops, but also Indo-European languages. For a long time 
the Basques were thought to be genetic descendants of 
pre-agricultural Europeans, with no significant genetic 
admixture of migrants from the Near East. But recent 
genetic investigations of ancient human remnants from 
a cave in Sierra Atapuerca (Spain) have not only revealed 
that people inhabiting this cave 5500-3500 years ago 
were genetically similar to early farmers from other parts 
of southern Europe, but also that their genetic pool was 
very close to current Basques [21]. So, why is FV Leiden 
mutation not found among the Basques but is quite 
common in other parts of Europe, while other genes are 
shared by Basques and other Europeans? This paradox 
can be explained by a phenomenon referred to as clinal 
genetic admixture. If a migrating group of people does 
not exterminate totally the local population, and there is 
some intermarriage, a dilution of the genes of the migrat-
ing group occurs. Neolithic expansion of agriculture into 
Europe consisted of hundreds of such intermarriages and 
gene dilutions, and finally in the most remote areas, such 
as the Basque country, most of the genes were derived 
from local population and only a small fraction from the 
invaders (we clearly see this phenomenon in Ireland, also 
located at the periphery of Europe) [22]. Early farmers 
migrated to Europe from Anatolia (nowadays: eastern 
Turkey) [23], and when the wave of migrating people 
and agriculture had reached southwestern Europe, the 
original Anatolian genepool must have been significantly 
diluted by the genes of hunter-gatherers previously resid-
ing in Europe. Most likely there were many FV Leiden 
carriers between early farmers from Anatolia, since the 
distribution of this polymorphism in Europe suggests 
that this mutation spread into Europe from this loca-
tion. But when the agricultural wave entered the Basque 
country, it is possible that FV Leiden genes were “dilut-
ed” to such a level that not a single individual with this 
mutation arrived in this area. There might be more such 
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places with no FV Leiden polymorphism in remote loca-
tions throughout pre-historic Europe, but in the Basque 
country, because of its geographic (mountainous terrain, 
far from trading routes) and cultural (language) isola-
tion, FV Leiden polymorphism has not been introduced 
by subsequent invaders in historic times (such as: the 
Romans, Goths, or Arabs) [21, 24]. By contrast, if early 
farmers were migrating over long distances and conse-
quently there was only a little clinal genetic admixture, 
in such areas we should expect a higher frequency of the 
genes of these early farmers, including FV Leiden poly-
morphism. Indeed, in southern Scandinavia FV Leiden is 
highly prevalent, and archaeological investigations have 
revealed that many farmers arrived to this area direct-
ly from southern Europe, and in addition there was little 
intermarriage between these migrants and local hunter- 
gatherers [24, 25].
There is also another consequence of the Basque phe-
nomenon: if a lack of FV Leiden polymorphism among 
the Basques resulted from clinal genetic admixture, 
it suggests that before Neolithic migration of farmers 
from the Near East, the FV Leiden gene was not present 
among European hunter-gatherers. If our hypothesis that 
indeed there was no FV Leiden polymorphism in Europe 
before Neolithic migration from Anatolia is correct, this 
scenario would shed some light on the actual origin of 
this mutation and also on some important pieces of Euro-
pean pre-history.
where did FV Leiden actually develop?
For the time being, most researchers believe that the 
location of the source of FV Leiden mutation is not very 
controversial. Geographic distribution of FV Leiden [6, 
11] suggests that the founder of this mutation lived in the 
Near East, and the spread of FV Leiden mutation was 
associated with the invention of agriculture and migration 
of early farmers from Anatolia to Europe, Central Asia, 
and towards the Indian subcontinent. But this migration 
took place later than 9500 years ago (after the invention 
of agriculture), while the above-discussed genetic study 
[13] suggests that the founder of this mutation lived about 
21,000 years ago. Also, FV Leiden mutation is almost 
exclusively found among speakers of Indo-European 
and Semitic languages. Linguists generally agree that 
a common language, the ancestor of the two language 
families, existed about 25,000 years ago [26]. This 
chronology is in line with the genetic timing of this 
polymorphism. Taking into account these genetic and 
linguistic presumptions, there should be a period of at 
least 10,000 years when people with FV Leiden muta-
tion were living in the Near East but did not share this 
polymorphism with contemporary Europeans and people 
inhabiting other parts of the world, and simultaneously 
retained a high prevalence of FV Leiden polymorphism 
in this founder population. In our opinion, both condi-
tions were difficult to meet, especially during such a long 
period of time and considering the geography of the Near 
East, which – at least theoretically – allows rather smooth 
transmission of the genes in any geographic direction 
(even if a recent study demonstrated that pre-historic 
inhabitants of the Jordan Valley /nowadays: Israel and 
Jordan/ and Zagros mountains /nowadays: western Iran/ 
were strongly genetically differentiated [23], in our opin-
ion this finding could be explained by the geographic 
barrier formed by western edge of the Zagros). Unfor-
tunately, there are no written records coming from such 
a distant past (writing was invented much later). Also, 
DNA is poorly preserved in warm climates, not to men-
tion that potential archaeological material from that time 
is very scarce (the oldest known human remnants of 
a carrier of FV Leiden, about 3000 years old, come from 
excavations of the Urartu civilisation, nowadays east-
ern Turkey [27]; this Urartu individual, quite recent in 
terms of the discussed time perspective, cannot clarify 
the problem).
But we suggest that this puzzle could be solved if 
we assume that the population carrying FV Leiden poly-
morphism did not originally live in the Near East, but 
lived in a small isolated group elsewhere, with very 
limited possibility of genetic admixture, and moved 
into the Near East just before invention of agriculture. 
Such a scenario would explain the high prevalence of FV 
Leiden mutation in this founder population (and also in 
the current Near East). Also, this scenario would explain 
why pre-Neolithic Europe was probably free of FV 
Leiden polymorphism. But is such a storyline realistic? 
However strange, very recent genetic investigations of 
ancient human remnants from the Near East (researchers 
have extracted genetic material from the petrous bone, 
where DNA is better preserved) revealed that Neolith-
ic inhabitants of the Near East derived a significant part 
of their genetic pool from the so-called Basal Eurasians, 
a hypothetical kind of ancestry that no longer exists in 
pure form, but has mixed into modern Europeans and 
other people from the Near and Middle East, South Asia, 
and North Africa. Basal Eurasians represent one of the 
hypothetical lineages that developed after the separation 
of non-African populations from Africans. It is estimat-
ed that about 44% of the genetic pool of early farmers 
from the Near East was derived from Basal Eurasians 
[28], and that this ancestry significantly contributed to 
the genetic pool of modern Europeans. Interestingly, the 
Basal Eurasian genome uncovered by this study had no 
Neanderthal admixture, which is strange, since it is the 
Near East where modern humans mixed with the Nean-
derthals [23]. Most likely, Basal Eurasians lived out-
side of the Near East, somewhere where there were no 
Neanderthals (this human species inhabited Europe and 
western Asia, but not Africa) and also no modern humans 
with sub-Saharan African genetic pool. We think that an 
isolated location in northern Africa seems to meet all of 
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these criteria. Such an area, located between the moun-
tains and deserts of Sahara and the Mediterranean Sea, 
would allow genetic isolation, even for such a long peri-
od as 10,000 years. Thus, in our opinion it is possible that 
FV Leiden mutation originally developed among Basal 
Eurasians who lived in Africa north of Sahara. It would 
be interesting to investigate if this population actually 
carried this polymorphism. With the laboratory methods 
used by Lazaridis et al. [23], such research seems tech-
nically feasible. 
Finally, one may ask why this hypothetical popula-
tion, carrying FV Leiden polymorphism, moved from 
their isolated homeland in northern Africa toward the 
Near East? There should be something that occurred 
shortly before 10,000 years ago and forced these people 
to migrate. And there is actually a well-known potential 
event: the Younger Dryas. During this geological peri-
od, approximately 12,000 years ago, a dramatic climate 
cooling occurred, with an average temperature decline of 
2-6oC throughout the Northern Hemisphere. During the 
Younger Dryas, which lasted about 1,000 years, much of 
Europe transformed into a cold desert. Also North Africa 
became extremely arid, with drying and expansion of the 
Sahara Desert [29]. But the Near East (particularly the 
Jordan Valley) remained relatively moist and provided 
a potential refuge for people who were driven out of their 
homeland by the sudden climate change [30, 31]. The 
invention of agriculture and animal husbandry, which 
occurred in the Near East some 2,000 years later among 
a population carrying a substantial genetic pool of Bas-
al Eurasians [23, 28], gave those people an enormous 
advantage over hunter-gatherers and probably enabled 
a successful spread of FV Leiden polymorphism.
The authors declare no conflict of interest.
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